CME & CE Events Calendar
Plan Your Learning.
One Month at a Time.
Every live event, webcast, and in-person symposium from PER's faculty — laid out so you can find your next CME, NCPD, or COPE credit in a glance.
June 2023
5 activities
- In-Person + Virtual Event
HER2+ Breast Cancer Tumor Board: Navigating Current and Evolving Strategies from Early Stages to Metastases
Hyatt Regency
- In-Person + Virtual Event
Medical Crossfire®: Experts Address Burning Questions in DLBCL—Sequencing CD19-Targeted Therapies, Strategies Post-CAR T Relapse, Novel Agents, and More!
JW Marriott
- In-Person + Virtual Event
Medical Crossfire®: Multidisciplinary Management of TNBC: Immunotherapy, PARP, TROP2, Oh My!
- In-Person + Virtual Event
Medical Crossfire®:Everything You Need to Know About the PARP Inhibitor Combinations in Prostate Cancer Care: Why? For Whom? And When?
Hilton Chicago
- In-Person + Virtual Event
The Top 10 Oncogenic Drivers in NSCLC for 2023: What You Need to Know on Tumor Testing, Targets, and Treatment Strategies to Move the Field Forward
JW Marriott
6 activities
B-Cell Tumor Board: Rendering Real World Personalized Treatment Plans in CLL/SLL and MCL Through the Lens of Emerging BTKi Evidence
- In-Person + Virtual Event
Improving Outcomes in Autoimmune Hemolytic Anemias at the Intersection Between Hematology and Oncology Care
Chicago, IL
- In-Person + Virtual Event
Medical Crossfire®: Bridging Precision Medicine Techniques and Emerging Treatments in Metastatic Colorectal Cancer
JW Marriott
- In-Person + Virtual Event
Medical Crossfire®: Leveraging Multidisciplinary Teams in Early-Stage Breast Cancer When the Goal is Cure
JW Marriott
- In-Person + Virtual Event
Show Me The Data™: Do We Have Sea Change for Novel Approaches in HR+/HER2- Breast Cancer? CDK, PI3K/AKT, ADC, and Next-Gen SERD Strategies Assessed
- In-Person + Virtual Event
Staying Abreast of the Prostate Cancer Treatment Paradigm From Risk Stratification to Adaptive Sequencing Strategies
3 activities
- In-Person + Virtual Event
Engaging the Multidisciplinary Care Team to Optimize Care of Patients With EGFR Mutation-Positive NSCLC: A Lung Cancer Tumor Board
- In-Person + Virtual Event
Expanding the Armamentarium of Actionable Mutations in NSCLC: Uncovering the Potential of CEACAM5 as a Therapeutic Target
- In-Person + Virtual Event
Live “Hot Seat”: Experts Face Your Hot-Button Questions on Maximizing PARP Inhibitors in Patients with CRPC
Hyatt Regency
1 activity
1 activity
1 activity
1 activity
Dates reflect each activity’s scheduled program days. Session times and full agendas are listed on the activity page.